OncoZenge AB

ABActive

Org 5592619968Gustavslundsvägen 34, 167 51 BrommaManufacture of pharmaceutical preparations· NACE 2120Est. 2020 · 5 years old5-9 employees

Overview Financials People & ownership Related companies

OncoZenge AB is a Swedish AB based in Bromma, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2020, the company reported revenue of SEK 1K in its latest annual filing.

Revenue 2024

SEK 1K

EBITDA margin

-868500.0%

+45% vs 2023

Net profit 2024

SEK -8,7M

+45% vs 2023

Key ratios

See full ratios →

87.0%

This company

20202024

3.1×

This company

20202024

-76.0%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 1K	—
EBITDA	SEK -8,7M	+45%
Net profit	SEK -8,7M	+45%
Total assets	SEK 11,4M	-44%
Equity	SEK 10M	-47%
Employees	—	—

Contact

Address

Gustavslundsvägen 34, 167 51 Bromma

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of OncoZenge AB?

OncoZenge AB is registered with Bolagsverket / SCB under Org 5592619968.

What is the revenue of OncoZenge AB?

OncoZenge AB reported revenue of SEK 1K in 2024.

Who is the CEO of OncoZenge AB?

Stian Kildal is the CEO of OncoZenge AB.

Who is the chairman of OncoZenge AB?

Per Daniel Ehrenstråhle chairs the board of OncoZenge AB.

Where is OncoZenge AB headquartered?

OncoZenge AB's registered address is Gustavslundsvägen 34 5 Tr.

OncoZenge AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on OncoZenge AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on OncoZenge AB